Elevating equity of voices for diverse patients with hereditary rare diseases
A postdoctoral fellowship in genomic science and health equity, cosponsored by the National Institutes of Health’s (NIH) National Human Genome Research Institute (NHGRI) and the Food and Drug Administration’s (FDA) Office of Minority Health and Health Equity (OMHHE), is open for applications.
The fellowship program is designed to prepare fellows to use genetic, genomic and pharmacogenomic approaches to advance minority health and health equity and train them in the research methodology and medical product development processes that facilitate the delivery of drugs, biologics and devices from bench to bedside.
The fellow will gain unique experiences by working closely with mentors at both FDA and NIH, including the opportunity to advance their knowledge of health disparity and regulatory sciences.
More than 30 million Americans — nearly 1 in 10 — have a rare disease. And there is a disproportionate burden for racial and ethnic minority patients who have a hereditary rare disease. Fellows who are interested in mixed methods studies at the intersection of health equity and rare disease research are encouraged to apply.
The fellow selected for this position will pursue research broadly related to:
Applicants must meet the following requirements:
Applications are currently being accepted and will be screened on a rolling basis until the position is filled. The fellow is expected to start in summer or fall 2022. For questions about the fellowship program please contact Jamil B. Scott, Ph.D., M.P.H., at [email protected] or Christine Lee, Pharm.D., Ph.D., at [email protected].
Interested candidates should submit the following to Jamil B. Scott, Ph.D., M.P.H., at [email protected]:
This position is subject to a background investigation. The NIH is dedicated to building a diverse community in its training and employment programs.